104 related articles for article (PubMed ID: 2025578)
21. Analysis of the c-myc and N-ras genes in acute myelogenous leukemia cells which manifest the constitutive expression of the c-myc gene.
Kadam P; Steele P; Li YQ; Preisler H
Anticancer Res; 1993; 13(3):747-51. PubMed ID: 8317907
[TBL] [Abstract][Full Text] [Related]
22. Altered expression of growth-regulated protooncogenes in human malignant plasma cells.
Palumbo AP; Pileri A; Dianzani U; Massaia M; Boccadoro M; Calabretta B
Cancer Res; 1989 Sep; 49(17):4701-4. PubMed ID: 2667753
[TBL] [Abstract][Full Text] [Related]
23. Selective expression of one c-myc allele in two human myeloma cell lines.
Kuehl WM; Brents LA; Chesi M; Bergsagel PL
Cancer Res; 1996 Oct; 56(19):4370-3. PubMed ID: 8813127
[TBL] [Abstract][Full Text] [Related]
24. Complex translocation disrupts c-myc regulation in a human plasma cell myeloma.
Hollis GF; Gazdar AF; Bertness V; Kirsch IR
Mol Cell Biol; 1988 Jan; 8(1):124-9. PubMed ID: 3275865
[TBL] [Abstract][Full Text] [Related]
25. Proto-oncogene analysis in multiple myeloma.
Ladanyi M; Wang S; Niesvizky R; Feiner H; Michaeli J
Am J Pathol; 1992 Oct; 141(4):949-53. PubMed ID: 1415486
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of c-myc-mRNA and c-MYC-protein during terminal neoplastic B-cell differentiation.
Greil R; Loidl P; Fasching B; Huber H
Curr Top Microbiol Immunol; 1992; 182():215-21. PubMed ID: 1490357
[No Abstract] [Full Text] [Related]
27. Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma.
Fabris S; Storlazzi CT; Baldini L; Nobili L; Lombardi L; Maiolo AT; Rocchi M; Neri A
Genes Chromosomes Cancer; 2003 Jul; 37(3):261-9. PubMed ID: 12759924
[TBL] [Abstract][Full Text] [Related]
28. Chromosome 8q24.1/c-MYC abnormality: a marker for high-risk myeloma.
Glitza IC; Lu G; Shah R; Bashir Q; Shah N; Champlin RE; Shah J; Orlowski RZ; Qazilbash MH
Leuk Lymphoma; 2015 Mar; 56(3):602-7. PubMed ID: 24844357
[TBL] [Abstract][Full Text] [Related]
29. [Expression of pituitary tumor transforming gene and C-myc gene in patients with multiple myeloma].
Li DQ; Chen P; Shao JH; Dong XB; Chang YL; Zhao HY; Zhou YW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1238-41. PubMed ID: 19840458
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of c-myc messenger RNA in primary and metastatic lesions of carcinoma of the stomach.
Onoda N; Maeda K; Chung YS; Yano Y; Matsui-Yuasa I; Otani S; Sowa M
J Am Coll Surg; 1996 Jan; 182(1):55-9. PubMed ID: 8542090
[TBL] [Abstract][Full Text] [Related]
31. c-myc gene expression in a leukemic T-cell line bearing a t(8;14) (q24;q11) translocation.
Soudon J; Bernard O; Mathieu-Mahul D; Larsen CJ
Leukemia; 1991 Jan; 5(1):60-5. PubMed ID: 1705637
[TBL] [Abstract][Full Text] [Related]
32. The biological effects of antisense N-myc expression in human neuroblastoma.
Schmidt ML; Salwen HR; Manohar CF; Ikegaki N; Cohn SL
Cell Growth Differ; 1994 Feb; 5(2):171-8. PubMed ID: 8180130
[TBL] [Abstract][Full Text] [Related]
33. A 3' truncation of myc caused by chromosomal translocation in a human T-cell leukemia is tumorigenic when tested in established rat fibroblasts.
Aghib DF; Bishop JM
Oncogene; 1991 Dec; 6(12):2371-5. PubMed ID: 1766681
[TBL] [Abstract][Full Text] [Related]
34. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.
Nagoshi H; Taki T; Hanamura I; Nitta M; Otsuki T; Nishida K; Okuda K; Sakamoto N; Kobayashi S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
Cancer Res; 2012 Oct; 72(19):4954-62. PubMed ID: 22869583
[TBL] [Abstract][Full Text] [Related]
35. Analysis of methylation in the c-MYC gene in five human myeloma cell lines.
Ohtsuki T; Nishitani K; Hatamochi A; Yawata Y; Namba M
Br J Haematol; 1991 Feb; 77(2):172-9. PubMed ID: 2004018
[TBL] [Abstract][Full Text] [Related]
36. MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy.
Holien T; Misund K; Olsen OE; Baranowska KA; Buene G; Børset M; Waage A; Sundan A
Oncotarget; 2015 Sep; 6(26):22698-705. PubMed ID: 26087190
[TBL] [Abstract][Full Text] [Related]
37. Provirus integration at the 3' region of N-myc in cell lines established from thymic lymphomas spontaneously formed in AKR mice and a [(BALB/c x B6)F1----AKR] bone marrow chimera.
Yano Y; Kobayashi S; Yasumizu R; Tamaki J; Kubo M; Sasaki A; Hasan S; Okuyama H; Inaba M; Ikehara S
Jpn J Cancer Res; 1991 Feb; 82(2):176-83. PubMed ID: 1900822
[TBL] [Abstract][Full Text] [Related]
38. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
39. A possible mechanism of inability of immunoglobulin heavy-chain production in Bence-Jones type myeloma cells.
Sakai A; Kawano MM; Tanabe O; Kuramoto A
Int J Hematol; 1993 Dec; 59(1):31-40. PubMed ID: 8161734
[TBL] [Abstract][Full Text] [Related]
40. [Repression of rearranged c-myc expression in murine cell hybrids].
Oikawa T
Hokkaido Igaku Zasshi; 1990 Jul; 65(4):351-61. PubMed ID: 2227789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
